Ind-Swift Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has submitted to the stock exchange a statement of deviation or variation under SEBI's Listing Obligation and Disclosure Requirements Regulation 32. This regulation requires listed companies to report any deviation or variation in the use of funds raised through public issues, rights issues, or preferential issues, compared to the purpose disclosed in the offer document. The specific details of the deviation or variation are not provided in the headline announcement, but the filing itself indicates the company is complying with disclosure norms regarding any change in the end-use of proceeds.
For retail investors, this is a compliance filing rather than a major corporate action. If the deviation is material, it could raise questions about the company's governance and the originally intended use of funds, but without further details from the company the market impact is likely neutral.